This statement is made on behalf of Hikma Pharmaceuticals PLC, including all its subsidiaries and the companies owned or controlled by it, in accordance with the United Kingdom’s Modern Slavery Act 2015. It covers the reporting period of January 1st, 2023 to December 31st, 2023. ...